Insider buying last 90 days
No open-market insider purchases were filed for CON in the last 90 days.
From Form 4 filings, dated to when each was filed.
Sep 28 close
This week's only notable item is a comparison piece weighing Concentra Group (CON) against Medpace (MEDP) on value grounds, prompted by ongoing investor interest in medical services names. No results, guidance, deal or regulatory news accompanied the stock's move, and the comparison itself does not resolve the question it raises.
CON closed at $35.36, up 1% on the day, sitting above both its 50-day average of $33.85 and its 200-day average of $26.32, with the shorter average also above the longer one. The GekkoIndex reads 55.2, placing the stock in the Neutral zone, little changed over the past five sessions. Price remains 6.9% below the Gekko Fair Value estimate of $37.97.
The next earnings report is scheduled for 5 November 2026 after the close, 37 days out and beyond a typical 20-trading-day holding window; the prior report on 7 May 2026 saw EPS of $0.40 against a $0.34 estimate, with a 5.9% reaction, and the company has beaten estimates in 5 of the last 8 quarters. No insider, Congress, or unusual options activity appears in the current windows, and seasonality data is insufficient for a read. Consensus analyst target sits at 41, implying 16% upside from current levels.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Concentra Group Holdings Parent scores 3 supportive, 1 mixed and 0 headwinds across the 4 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed0 headwinds
Above 50 and 200-day
Close $35.36 is above the 50-day ($33.85) and 200-day ($26.32) averages, and the 50-day is above the 200-day.
See the chart55.2, Neutral
Reading 55.2 is in the Neutral zone.
See the GekkoIndex6.9% below
Price is 6.9% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 37 days
Next report Nov 5, 2026, 37 days away — outside a typical 20-trading-day hold.
See earningsNo data
Not enough years of history for a seasonal read.
A description of current data, not a recommendation. How this page works
Concentra Group Holdings Parent closed at $35.36 on Sep 28, 2026, +71.8% over the past year, inside a 52-week range of $18.55 to $36.71.
Use the left and right arrow keys to read daily values.
Put CON on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Concentra Group Holdings Parent runs health services aimed at people hurt or affected on the job, serving businesses across the United States. Its offerings span care for workplace injuries, walk-in urgent treatment, lab and imaging testing, checkups meant to catch problems early, and programs built around what individual employers need, plus efforts to keep workers well overall. Patients get to these services through a set of clinics dedicated to occupational care and locations placed directly at employer worksites, which has made the company a familiar name in this space.
The company also runs a few more targeted offerings. Concentra Telemed lets people get remote care for job-related injuries and illnesses while giving employers extra support options. Concentra Pharmacy handles medication needs, and Concentra Medical Compliance Administration acts as an outside manager for employer drug testing programs, covering both workforces under regulation and those without such requirements. Its clients are largely companies looking to handle health and testing obligations for their staff, and the firm sits under Select Medical Corporation as a subsidiary.
The company traces back to 1979 and runs its operations from Mechanicsburg, Pennsylvania. Shares trade on the NYSE under the ticker CON.
Concentra Group Holdings Parent’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 55.2, in the Neutral zone, down 0.2 points over five sessions.
Down 0.2 points over five sessions.
Reading for Sep 28, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 10 | +3.7% | +1.1% | ||
| Accumulation | 200 | +0.4% | +2.7% | ||
| Neutral (current zone) | 267 | +0.4% | +1.6% | ||
| Distribution | 61 | +0.7% | +1.4% | ||
| Selling | 2 | Too few readings yet | |||
Average CON share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Concentra Group Holdings Parent trades 6.9% below Gekko Fair Value of $37.97, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Concentra Group Holdings Parent shares are worth, recalculated every trading day.
$37.97
Gekko Fair Value, Sep 26, 2026
6.9% Undervalued
No open-market insider purchases were filed for Concentra Group Holdings Parent, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for CON in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in CON were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Concentra Group Holdings Parent has been buying back its own shares.
From company filings.
0of the funds Gekko tracks hold CON.
Concentra Group Holdings Parent reports on Nov 5, 2026, after the close (37 days away), and beat the EPS estimate in 5 of its last 8 reports.
Nov 5, 2026
Expected after the close, 37 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| May 7, 2026 | $0.40 est $0.34 | $569.6M est $553.5M | +5.9% |
| Jan 28, 2026 | $0.28 est $0.23 | $539.1M est $532.1M | −0.3% |
| Nov 6, 2025 | $0.39 est $0.38 | $572.8M est $532.0M | +1.0% |
| Aug 7, 2025 | $0.37 est $0.37 | $550.8M est $537.4M | +8.4% |
| May 7, 2025 | $0.32 est $0.32 | $500.8M est $496.1M | −2.7% |
| Mar 3, 2025 | $0.17 est $0.17 | $465.0M est $486.6M | −0.6% |
| Oct 31, 2024 | $0.37 est $0.36 | $489.6M est $492.6M | −3.4% |
| Aug 1, 2024 | $0.50 est $0.49 | $477.9M est $473.7M | −2.8% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Concentra Group Holdings Parent is $41.00, +16.0% from the last close.
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Concentra Group Holdings Parent’s market cap is $4.52B, with a P/E ratio of 22.5 and revenue of $2.29B over the last twelve months.
1 headline about Concentra Group Holdings Parent from the past week, newest first, each linking to the publisher.
Concentra Group Holdings Parent’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| LHLabcorp | Accumulation | 3.9% below |
| GHGuardant Health | Neutral | 0.5% above |
| SOLVSolventum | Neutral | 16.4% below |
| EHCEncompass Health | Neutral | 7.6% above |
| DVADaVita | Accumulation | 15.9% below |
| BTSGBrightSpring Health Services | Accumulation | 7.4% below |
A peer links to its own page where one exists.
Concentra Group Holdings Parent’s market cap is $4.52B at the Sep 28, 2026 close of $35.36, with 127.5M shares outstanding. The shares trade on a P/E ratio of 22.5.
The consensus analyst 12-month price target for Concentra Group Holdings Parent is $41.00, +16.0% from the last close. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Concentra Group Holdings Parent is undervalued: the Sep 28, 2026 close of $35.36 is 6.9% below Gekko Fair Value of $37.97. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Concentra Group Holdings Parent is expected to report on Nov 5, 2026, after the market closes (37 days away). Analysts expect earnings of $0.45 per share on revenue of $605.2M. Concentra Group Holdings Parent beat the earnings estimate in 5 of its last 8 reports, moving 3.1% on average across the report.
Concentra Group Holdings Parent’s 52-week high is $36.71 and its 52-week low is $18.55; it closed at $35.36 on Sep 28, 2026, +71.8% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 4 items with data read as supportive (trend, fair value and earnings risk), 1 as mixed (gekkoindex). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.